Marksans Pharma Ltd
BSE:524404
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marksans Pharma Ltd
BSE:524404
|
IN |
|
F
|
Fintech SA
WSE:FTH
|
PL |
|
C
|
CSL Ltd
XMUN:CSJ
|
AU |
|
D
|
Danaher Corp
F:DAP
|
US |
|
A
|
Applied Energetics Inc
OTC:AERG
|
US |
|
E
|
Enphase Energy Inc
F:E0P
|
US |
|
Castle Minerals Ltd
ASX:CDT
|
AU |
|
K
|
Komputronik SA w restrukturyzacji
WSE:KOM
|
PL |
|
Circle Internet Group Inc
F:ET9
|
US |
|
I
|
Ingevity Corp
F:IGX
|
US |
|
O
|
Ocean Geoloop AS
OSE:OCEAN
|
NO |
Intrinsic Value
Is MARKSANS undervalued or overvalued?
See the intrinsic value estimate for 
Marksans Pharma Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MARKSANS looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with MARKSANS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Marksans Pharma Does
Marksans Pharma makes generic medicines and over-the-counter healthcare products. It develops, manufactures, and sells tablets, capsules, and other finished dosage forms for pain relief, cough and cold, digestive health, allergies, and similar everyday treatments. The company works mainly as a manufacturer of branded and unbranded generics rather than as a drug discoverer, so its business is tied to producing approved medicines that match existing active ingredients.
- Headquarters
- India IN
- Employees
- 1 840
- IPO date
- Apr 3, 2002
Marksans Pharma has a narrow economic moat
Marksans Pharma Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Marksans Pharma Ltd
Earnings Waterfall
Marksans Pharma Ltd
The intrinsic value for Marksans Pharma Ltd (524404) under the Base Case is hidden INR.
Compared with the current market price of 294.4 INR, the stock appears hidden.